Thursday, May 22, 2014
Publication and contact
Uracil enrichment in the
seed region of single guide RNAs (sgRNAs) decreases off-target binding by the
clustered, regularly interspaced
short palindromic repeats (CRISPR)-Cas9
Cell culture studies
suggest sgRNA sequence composition influences Cas9 binding specificity. In
mouse embryonic stem cells stably expressing Cas9 and transfected with
sgRNAs, ChIP-seq experiments revealed thousands of binding sites for the Cas9
protein. In the cells, genome editing was detected at 4 of 4 on-target sites
and only 1 of 295 potential off-target sites for 4 sgRNAs. In the cells,
sgRNAs with uracil-rich seed regions or downstream regions were expressed at
lower levels and bound to fewer off-target sites than sgRNAs without uracil
enrichment at the sites. Next steps could include establishing guidelines for
engineering uracil-rich sgRNAs to improve editing-site selectivity.
SciBX 7(20); doi:10.1038/scibx.2014.599
Published online May 22, 2014
Patent and licensing status
Wu, X. et al. Nat.
Biotechnol.; published online April 20, 2014;
Contact: Phillip A. Sharp, Massachusetts Institute of
Technology, Cambridge, Mass.
Contact: Feng Zhang, Broad Institute of MIT and Harvard, Cambridge,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]